TY - JOUR
T1 - Psychological Interventions and Genetic Testing
T2 - Facilitating Informed Decisions About BRCA1/2 Cancer Susceptibility
AU - Shoda, Yuichi
AU - Mischel, Walter
AU - Miller, Suzanne M.
AU - Diefenbach, Michael
AU - Daly, Mary B.
AU - Engstrom, Paul F.
N1 - Funding Information:
Preparation of this paper was supported in part by NCI Grants CA46591, CA58999, CA61280, and CA06927, ACS Grant PBR-72, HG01189, NIMH Grants MH39349 and MH45994, and appropriations from the Commonwealth of Pennsylvania. We are indebted to Rob Sipps, Leeann Speechley, and Lloyd Ohls for their assistance.
PY - 1998
Y1 - 1998
N2 - Genetic testing for inherited cancer susceptibility, based on the recently identified BRCA1 and BRCA2 genes, will soon be available on a large scale. However, at present, genetic test results do not lead to clearly indicated diagnostic or preventive measures, and the nature of the psychological impact of BRCA1/2 testing is still largely unknown. This uncertainty, combined with preliminary evidence suggesting significant individual differences in reactions to genetic susceptibility feedback, constitutes a unique challenge for any individual contemplating such testing. We outline the nature of this challenge and then propose an intervention strategy designed to help individuals make deeply processed and psychologically well-informed decisions with regard to their genetic susceptibility. The intervention is guided by recent research findings and theory on the cognitive-emotional processing of cancer-risk information. Specifically, the goal is to prepare the individual for genetic testing by (1) cognitively and emotionally activating, or "preliving," the individual's potential reactions to testing feedback; (2) facilitating accurate appraisal of the individual's cognitive-emotional reactions; and (3) enabling the individual to process these reactions through the use of well-established clinical techniques.
AB - Genetic testing for inherited cancer susceptibility, based on the recently identified BRCA1 and BRCA2 genes, will soon be available on a large scale. However, at present, genetic test results do not lead to clearly indicated diagnostic or preventive measures, and the nature of the psychological impact of BRCA1/2 testing is still largely unknown. This uncertainty, combined with preliminary evidence suggesting significant individual differences in reactions to genetic susceptibility feedback, constitutes a unique challenge for any individual contemplating such testing. We outline the nature of this challenge and then propose an intervention strategy designed to help individuals make deeply processed and psychologically well-informed decisions with regard to their genetic susceptibility. The intervention is guided by recent research findings and theory on the cognitive-emotional processing of cancer-risk information. Specifically, the goal is to prepare the individual for genetic testing by (1) cognitively and emotionally activating, or "preliving," the individual's potential reactions to testing feedback; (2) facilitating accurate appraisal of the individual's cognitive-emotional reactions; and (3) enabling the individual to process these reactions through the use of well-established clinical techniques.
KW - Behavioral medicine
KW - Breast cancer risk
KW - Cognitive-affective processing
KW - Coping styles
KW - Decision-making, BRCA1/2
KW - Genetic testing
KW - Health psychology
UR - https://www.scopus.com/pages/publications/0002979562
U2 - 10.1023/A:1026297618180
DO - 10.1023/A:1026297618180
M3 - Article
AN - SCOPUS:0002979562
SN - 1068-9583
VL - 5
SP - 3
EP - 17
JO - Journal of Clinical Psychology in Medical Settings
JF - Journal of Clinical Psychology in Medical Settings
IS - 1
ER -